Evaluation of Ferric and Ferrous Iron Therapies in Women with Iron Deficiency Anaemia

Yang, S. S., Lin, S. H., Chu, P. L., Wu, S. C., Wu, C. C., Tsai, W. S., & Lin, Y. F. (2002). The Effect of Low-Dose Deferoxamine on Anemia in Iron-Overloaded Hemodialysis Patients. Journal of Medical Sciences, 22(6), 283-288. https://www.airitilibrary.com/Article/Detail?DocID=10114564-200212-201305090027-201305090027-283-288
Habib, M. A., Greenow, C. R., Soofi, S. B., Ali, N., Nausheen, S., Ahmed, I., Bhutta, Z. A., & Black, K. I. (2018). Prevalence and determinants of iron deficiency anemia among non-pregnant women of reproductive age in Pakistan. Asia Pacific Journal of Clinical Nutrition, 27(1), 195-203. https://doi.org/10.6133/apjcn.042017.14
Hussain, I., Bhoyroo, J., Butcher, A., Koch, T. A., He, A., & Bregman, D. B. (2013). Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia. Anemia, 2013(), 6-15. https://doi.org/10.1155/2013/169107
Koch, T. A., Myers, J., & Goodnough, L. T. (2015). Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations. Anemia, 2015(), 49-58. https://doi.org/10.1155/2015/763576
Khalafallah, A. A., & Dennis, A. E. (2012). Iron Deficiency Anaemia in Pregnancy and Postpartum: Pathophysiology and Effect of Oral versus Intravenous Iron Therapy. Journal of Pregnancy, 2012(), 257-266. https://doi.org/10.1155/2012/630519